Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.21B P/E - EPS this Y 325.00% Ern Qtrly Grth -
Income 11.74M Forward P/E 30.60 EPS next Y 88.90% 50D Avg Chg 7.00%
Sales 248.37M PEG 1.96 EPS past 5Y - 200D Avg Chg 4.00%
Dividend N/A Price/Book N/A EPS next 5Y 35.60% 52W High Chg -20.00%
Recommedations 1.80 Quick Ratio 3.47 Shares Outstanding 275M 52W Low Chg 58.00%
Insider Own 1.86% ROA 7.44% Shares Float 268.88M Beta 1.31
Inst Own 50.88% ROE - Shares Shorted/Prior 42.14M/38.83M Price 4.59
Gross Margin 71.30% Profit Margin 4.73% Avg. Volume 2,709,170 Target Price 7.80
Oper. Margin 22.22% Earnings Date Nov 5 Volume 2,813,672 Change 2.23%
About MannKind Corporation

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company's product pipeline also includes Tyvaso DPI (Treprostinil), an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.

MannKind Corporation News
11/09/24 MannKind Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
11/08/24 Q3 2024 MannKind Corp Earnings Call
11/08/24 MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
11/07/24 MannKind (MNKD) Q3 2024 Earnings Call Transcript
11/07/24 MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say
11/07/24 MannKind (MNKD) Matches Q3 Earnings Estimates
11/07/24 MannKind: Q3 Earnings Snapshot
11/07/24 MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update
11/05/24 MannKind to Present at 2024 UBS Healthcare Conference
11/04/24 High Growth Tech Stocks To Watch In November 2024
11/04/24 MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases
11/01/24 MannKind Corporation (MNKD) Hits Fresh High: Is There Still Room to Run?
10/31/24 MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024
10/30/24 First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
10/09/24 MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ...
10/09/24 Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
10/07/24 Why MannKind (MNKD) Could Beat Earnings Estimates Again
10/04/24 Exploring High Growth Tech Stocks In The United States October 2024
10/04/24 MannKind (MNKD) Just Overtook the 20-Day Moving Average
09/30/24 More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®)
MNKD Chatroom

User Image ZeroDog Posted - 5 hours ago

$MNKD libtards are reliably compliant with the deep state narrative like the good subjects that they are and want to be

User Image Rollertb Posted - 5 hours ago

$MNKD Quality of T1D Life

User Image Playthegame06 Posted - 7 hours ago

$MNKD I want everyone to raise your hand (hit the like button) if you heard Trump say during the Campaign.....HE KNOWS NOTHING ABOUT PROJECT 2025???? JD Vance also said he knows nothing about Project 2025. Today's NEWS....Trump's Transition Team turns to Project 2025. Trump has hired several people who created the Manifesto. Will this man ever stop LYING to the American People??? My God!!!

User Image grampslol Posted - 7 hours ago

$MNKD Whoa! Up 4 pennies AH; so very very interesting indeed

User Image kevinmik Posted - 8 hours ago

$mnkd On December 18, 2008, Mannkind issued top line results for an Afrezza Phase III Study and here they are 16 years later getting ready to issue top line results in December 2024, for yet another Phase III study. Afrezza has been studied more than carter has pills and the upcoming Phase III Study results to be issued in December 2024, will hopefully be the the last clinical trial done that will either finally fulfill Alfred Mann vision to see Afrezza become a blockbuster drug or relegate it to be a very small niche drug. https://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-reports-top-line-results-two-pivotal-phase-3-clinical MannKind Reports Top-Line Results from Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 12/18/08

User Image ChillyMutt Posted - 8 hours ago

$MNKD I guess Binder’s “Special Project” is cashing out.

User Image evetsoloccip Posted - 8 hours ago

$MNKD Read It And Weep.......

User Image Golf365 Posted - 9 hours ago

$MNKD That Nate loving ultra lib masspd is out there bragging that it blocked me. What gives Nate the right to belittle everyone that doesn’t agree with his bs? Typical ultra liberal, block you and talk shi* about you. How Nate, by the way, what happened to that Kamala Harris? I know what happened, the TRUMP TRAIN took care of that ultra liberal!

User Image kevinmik Posted - 9 hours ago

$mnkd The IcoN-1 Study now has 25 out of 26 locations in the United States recruting patients. The study will very likely meet it's enrollment goal quickly and an interim analysis completed in 2025.

User Image santinov Posted - 10 hours ago

$MNKD We are all anticipating that mikey will make a "Brilliant Statement" at some point in December that will illustrate the invisible genius behind all of the extraordinary things that he has done with Afrezza, V-Go and all the national and international attention he has generated because of his superior skills. I, like many of the pumpers, enthusiastically anticipate another round of earth shattering BS. I can certainly be said that mikey knows how to put the BS in "Brilliant Statement" OBTW.... it's 6 weeks ( and $3.16) to 10 in 24. That's 6.86 + 46.3% to get to 10! Mikey better put out some major BS to invigorate the Pumper Clan's narrative.

User Image Igotzthis Posted - 10 hours ago

$MNKD What’s up with Steve Binder selling 67,573 shares of stock. What does he know that we don’t.

User Image Igotzthis Posted - 11 hours ago

$MNKD JMO but December should be the month to remember. I invision debt being paid off and we get better clarity on what MNKD is up to. Maybe an update on the PED trial. Would be nice. Have a great weekend fellow longs.

User Image NatesNotes Posted - 11 hours ago

$MNKD Looks like another interesting session after hours -here's to more being wrong in the years ahead, eh? ;-) Have a great weekend, everyone! Cheers! #factsmatter

User Image neil36 Posted - 11 hours ago

$MNKD Nineteen of the past twenty days.

User Image kapy1544 Posted - 11 hours ago

$MNKD 1 day to go

User Image evetsoloccip Posted - 11 hours ago

$MNKD

User Image KabOOOM Posted - 11 hours ago

$MNKD Day 2. Missed 1 day. Have a good weekend bulls!

User Image santinov Posted - 11 hours ago

$MNKD Plastic bags with syringes.... our brilliant CEO Hey Clan is this why Damon Dash became CEO of the Year in 2018? Or was that mikey in the alley demonstrating why injections are bad? Can't figure it out: how a world class CEO cannot find any gravitas when you have this image of him. Tanner, Brazil, India, Australia. What continent hasn't he conquered?

User Image Kool_Aid_Mann Posted - 11 hours ago

$MNKD Bear raid in the final 5 minutes? I've got some powder ready for some 6.78's

User Image addiction2money Posted - 11 hours ago

$MNKD got a nickel. Went through this on another tight day and bought small incremental lots at market which kept SP up.

User Image santinov Posted - 12 hours ago

$MNKD The truth about mikey.... All the green at MNKD comes from Martine. ( that't where the money that gives the company credibility comes from ) The RED is a reminder to eveyone in the investment community of mikey's 8 year fiasco marketing Afrezza and his V-go joke. When Martine's hand is missing and mikey stands alone the strength of the company falters. Mikey struggles to maintain the legitimacy that he gets exclusively from Martine and the share price shows it's weakness. Today MNKD is a red wound in a sea of green. The reason for this is exactly the reason Major investment houses won't commit to to initiating coverage. The CEO of MNKD does not inspire enough confidence that companies like Morgan Stanley or Goldman Sachs would recommend " their" clients put their money behind mikey at any price. These companies have their reputations to maintain and powerful clients to advise. MNKD needs a CEO that can sit at the table with the big players. It isn't mikey!

User Image nomalarkey Posted - 12 hours ago

$MNKD is truly trading like

User Image Golf365 Posted - 12 hours ago

$MNKD It’s trying to go below that 6.77…F’N MC

User Image Preacherclint10 Posted - 12 hours ago

$MNKD bullish

User Image Preacherclint10 Posted - 12 hours ago

$MNKD https://youtu.be/jT22GyhOUTA?si=IFSNxOPVxLaizWW7

User Image Golf365 Posted - 13 hours ago

$MNKD Mike….hooper…binder….martine???

User Image JumboMike Posted - 13 hours ago

$MNKD crazy in this market we can't gain some traction, but don't worry Mike has a Christmas surprise for us! Lets hope its no a lump of coal?

User Image grampslol Posted - 13 hours ago

$MNKD Good money being spent self promoting the ceo of the afrezza company on social media platforms ? Asking for a friend.

User Image Golf365 Posted - 13 hours ago

$MNKD Hey Mike, what happened to Brazil 🇧🇷 and India?🇮🇳

User Image Golf365 Posted - 13 hours ago

$MNKD Ot…Elon will be the 1st Trillionaire.

Analyst Ratings
Oppenheimer Outperform Aug 28, 24
Rodman & Renshaw Buy Jun 13, 24
Cantor Fitzgerald Overweight May 9, 24
Cantor Fitzgerald Overweight Mar 15, 24
Cantor Fitzgerald Overweight Feb 28, 24
HC Wainwright & Co. Buy Jan 4, 24
Wedbush Outperform Oct 10, 23
HC Wainwright & Co. Buy Aug 14, 23
Cantor Fitzgerald Overweight Aug 8, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Castagna Michael Chief Executive Offi.. Chief Executive Officer Dec 14 Sell 4 200,482 801,928 2,148,665 12/15/23
Castagna Michael Chief Executive Offi.. Chief Executive Officer Nov 01 Sell 4.25 10,000 42,500 2,349,147 11/02/23
Castagna Michael Chief Executive Offi.. Chief Executive Officer Oct 02 Sell 4.08 10,000 40,800 2,359,147 10/03/23
Castagna Michael Chief Executive Offi.. Chief Executive Officer Sep 01 Sell 4.61 10,000 46,100 2,436,039 09/05/23
Thomson David EVP Genl Counsel & S.. EVP Genl Counsel & Secretary Aug 27 Sell 4.78 8,100 38,718 798,835 08/28/23
Castagna Michael Chief Executive Offi.. Chief Executive Officer Aug 01 Sell 4.5686 10,000 45,686 2,496,735 08/01/23
Castagna Michael Chief Executive Offi.. Chief Executive Officer Jul 03 Sell 4.04 10,000 40,400 2,506,735 07/07/23
Castagna Michael Chief Executive Offi.. Chief Executive Officer Jun 01 Sell 4.5302 10,000 45,302 2,516,735 06/02/23
Castagna Michael Chief Executive Offi.. Chief Executive Officer May 25 Sell 4.55 150,000 682,500 2,526,735 05/26/23
Thomson David EVP Genl Counsel & S.. EVP Genl Counsel & Secretary May 22 Sell 4.68 95,576 447,296 735,263 05/24/23
Castagna Michael Chief Executive Offi.. Chief Executive Officer May 22 Sell 4.69 150,000 703,500 2,331,735 05/24/23
Binder Steven B. Chief Financial Offi.. Chief Financial Officer May 22 Sell 4.68 47,810 223,751 838,324 05/24/23
Castagna Michael Chief Executive Offi.. Chief Executive Officer May 05 Sell 4.00 10,000 40,000 2,020,128 05/05/23
Castagna Michael Chief Executive Offi.. Chief Executive Officer Apr 03 Sell 4.1287 10,000 41,287 2,030,128 04/05/23
Castagna Michael Chief Executive Offi.. Chief Executive Officer Mar 01 Sell 5.2748 10,000 52,748 2,040,128 03/03/23
Thomson David EVP Genl Counsel & S.. EVP Genl Counsel & Secretary Aug 27 Sell 3.67 7,000 25,690 726,035 08/29/22
Galindo Alejandro EVP Endocrine Busine.. EVP Endocrine Business Unit Aug 22 Sell 3.85 4,615 17,768 777,075 08/23/22
Binder Steven B. Chief Financial Offi.. Chief Financial Officer Jul 31 Buy 2.93 791 2,318 728,997 08/01/22
Castagna Michael Chief Executive Offi.. Chief Executive Officer Jul 31 Buy 2.93 3,147 9,221 2,084,486 08/01/22
Tross Stuart A Chief People & Workp.. Chief People & Workpl Officer Jul 31 Buy 2.93 4,581 13,422 830,650 08/01/22
Galindo Alejandro EVP Endocrine Busine.. EVP Endocrine Business Unit Jul 31 Buy 2.93 5,000 14,650 781,690 08/01/22
HOOPER ANTHONY C Director Director Feb 28 Buy 2.71 40,000 108,400 338,394 03/01/22
MUNDKUR CHRISTINE Director Director Feb 28 Buy 2.71 27,675 74,999 254,493 03/01/22
Galindo Alejandro Chief Commercial Off.. Chief Commercial Officer Jan 31 Buy 3.17 1,804 5,719 539,790 02/09/22
Castagna Michael Chief Executive Offi.. Chief Executive Officer Jan 31 Buy 3.17 1,804 5,719 1,505,098 02/09/22
Tross Stuart A Chief People & Workp.. Chief People & Workpl Officer Jan 31 Buy 3.17 2,254 7,145 622,785 02/09/22
Binder Steven B. Chief Financial Offi.. Chief Financial Officer Jan 31 Buy 3.17 711 2,254 534,178 02/02/22
Thomson David EVP Genl Counsel & S.. EVP Genl Counsel & Secretary Aug 27 Sell 4.64 4,100 19,024 567,391 08/27/21